RECORDATI RARE DISEASES INC. recalls Caphosol Artificial Saliva (32 doses sachet box). 64 x 15 mL sachets aqueous solution…
Out of specification stability test result for the Caphosol B solution from process validation lots
Drawn from openFDA device enforcement reports. Filter by severity, status, state, year, or manufacturer.
Showing 85–96 of 123 recalls
Out of specification stability test result for the Caphosol B solution from process validation lots
Lack of sterility assurance.
Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
Devices contain potentially out-of-specification levels of endotoxins and lack of sterility assurance.
Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%
A software update corrected an issue where "low" and "terminal" battery alerts did not display on the screen to the user in specific circumstances when the device was not running patient therapy.
A software issue where "low" and "terminal" battery alerts did not display on the screen to the user in specific circumstances when the device was not running patient therapy.
Potential for breach of Tyvek seals.
Potential for breach of Tyvek seals.
Potential for breach of Tyvek seals.
Potential for breach of Tyvek seals.